A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants
Clinical trial NCT02447432 · COMPLETED
Trial details
- NCT number
- NCT02447432
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-11
- Primary completion
- 2016-01-23
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.